Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Citi
McKinsey
McKesson
Johnson and Johnson
Cantor Fitzgerald

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 9,504,744

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,504,744
Title:Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
Abstract: The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
Inventor(s): White; Christine A. (Rancho Santa fe, CA), Grillo-Lopez; Antonio J. (Rancho Santa Fe, CA)
Assignee: Biogen Inc. (Cambridge, MA)
Application Number:14/310,167
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,504,744
Patent Claims:see list of patent claims

Details for Patent 9,504,744

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Biogen Inc. (Cambridge, MA) 2019-08-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,504,744

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 0110460 Feb 15, 2001
United States of America 2014030263 Jan 30, 2014
United States of America 2014302018 Oct 09, 2014
United States of America 2017037139 Feb 09, 2017
United States of America 2018118844 May 03, 2018
United States of America 8557244 Oct 15, 2013
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Harvard Business School
McKinsey
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.